🔴 GH Research is trading at 5.2% down today as higher-for-longer interest rates pressure biotech stocks

GH Research is trading 5.2% down at $24.61 as elevated Treasury yields and persistent inflation concerns intensify risk-off pressure on growth-oriented biotechnology stocks.

• On September 24, 2026, weaker major indexes and expectations for higher-for-longer interest rates are adding to the pressure.
• XBI is down 2.04%; no new company-specific announcement was identified, while recent coverage highlights previously reported GH001 development progress.